In order to prevent spam,
this email address cannot be copied.
Schizophrenia Research Forum: Researcher Profile - Greg Price
Schizophrenia Research Forum - A Catalyst for Creative Thinking
Home Profile Membership/Get Newsletter Log In Contact Us
 For Patients & Families
What's New
Recent Updates
SRF Papers
Current Papers
Search All Papers
Search Comments
Research News
Conference News
Plain English
Current Hypotheses
Idea Lab
Online Discussions
Virtual Conferences
What We Know
Animal Models
Drugs in Trials
Research Tools
Community Calendar
General Information
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
SRF Team
Advisory Board
Support Us
How to Cite
Fan (E)Mail
The Schizophrenia Research Forum web site is sponsored by the Brain and Behavior Research Foundation and was created with funding from the U.S. National Institute of Mental Health.
Researcher Profile - Greg Price

First Name:Greg
Last Name:Price
Advanced Degrees:Ph.D.
Affiliation:Centre for Clinical Research in Neuropsychiatry
Street Address 1:Private Bag 1
Street Address 2:Claremont
State/Province:Western Australia
Zip/Postal Code:6010
Phone:61 8 9347 6493
Email Address:
(view policy) 
Member reports no financial or other potential conflicts of interest. [Last Modified: 10 January 2006]
View all comments by Greg Price
Clinical Interests:
rTMS, Schizophrenia
Research Focus:
Work Sector(s):
Medical hospital
Web Sites:
Reasearcher Bio
Research experience and expertise:
Research is primarily electrophysiological, using EEG, ERP, and rTMS in clinical research into schizophrenia, mood disorders, and attention deficit disorder. The use of electrophysiological features as endophenotypes feeding naturally into genetic research in schizophrenia at CCRN. Arising from Ph.D. studies, he has also developed (and patented) methods of co-analysing EEG, ERP and rTMS data in an attempt to increase the utility of electrophysiological investigations.
Top Papers
1. Mann, P., Price, G.W., Ritson, J.R., Young, E.S., 1990. Electrophysiological Identification of individuals susceptible to Pathological Intoxication. Touching Basis, 4(1):1-3.

2. Perros, P., Price, G.W., Young, E.S., Ritson, J.S. and Mann, P. (1992). Power spectral EEG analysis and EEG variability in obsessive - compulsive disorder. Brain Topography, 4(3):187-192.

3. Price, G., Young, E. S., Perros, P., Sadler, T. 1995. Acute Challenge ERP as a prognostic of stimulant therapy outcome in Attention-Deficit Hyperactivity Disorder. Biological Psychiatry, 37:25-33.

4. Price, G.W., 1997. The effect of pre stimulus alpha activity on the auditory P300 paradigm: A prospective study. Brain Topography, 9(3):169-176.

5. Price, G.W., 2000. The effect of selected pre stimulus activity on the auditory P300 paradigm: clinical application to treatment refractory schizophrenia. Schizophrenia Research , 41:463-472.

6. Price, G.W., Mann, P., Hills S., 2002. The impact of clozapine on electrophysiological features: How can we utilize the findings. International Journal of Psychiatry in Clinical Practice, 6:95-100.

7. Price, G.W. (2004). EEG-dependent ERP recording: using TMS to increase the incidence of a selected pre-stimulus pattern. Brain Research Protocols 12(3), 144-51.

8. Price, GW, Michie PM, Johnston J, Innes-Brown, H, Kent A, Clissa P, Jablensky AV, A multivariate electrophysiological endophenotype, from a unitary cohort, shows greater research utility than any single feature in the Western Australian Family Study of Schizophrenia. Biological Psychiatry, (In Press, Biological Psychiatry, 2005).

What are the top three papers (not yours) you have read recently?
Jandl M, Bittner R, Sack A, Weber B, Gunther T, Pieschl D, et al (2005 Jun.): Changes in negative symptoms and EEG in schizophrenic patients after repetitive Transcranial Magnetic Stimulation (rTMS): an open-label pilot study. Journal of Neural Transmission 112:955-67.
Fitzgerald PB, Benitez J, Daskalakis JZ, Brown TL, Marston NA, de Castella A, et al (2005 Aug.): A double-blind sham-controlled trial of repetitive transcranial magnetic stimulation in the treatment of refractory auditory hallucinations. Journal of Clinical Psychopharmacology 25:358-62.
Saba G, Verdon CM (2005 (PrePublish)): Transcranial Magnetic Stimulation in the treatment of schizophrenic symptoms: a double blind sham controlled study. Journal of Psychiatric Research.
If resources were not limited, what research projects would you pursue?
rTMS effects on negative symptoms in schizophrenia.
What is your leading hypothesis?
That electrophysiological evidence exists of schizophrenia, that can be utilised as an endophenotype.
What piece of missing evidence would help prove it?
rTMS effects upon electrophysiological measures that are particular to schizophrenia.
What is your fallback position?
That electrophysiological evidence exists of schizophrenia, but that is not amenable to rTMS modification.

Research Participants
Copyright © 2005- 2016 Schizophrenia Research Forum Privacy Policy Disclaimer Disclosure Copyright